Your browser doesn't support javascript.
loading
Assessment of the Monitor Unit Objective tool for VMAT in the Eclipse treatment planning system.
Jiménez-Puertas, Sara; Sánchez-Artuñedo, David; Hermida-López, Marcelino.
Afiliação
  • Jiménez-Puertas S; Servicio de Física y Protección Radiológica, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009, Zaragoza, Spain.
  • Sánchez-Artuñedo D; Servei de Física i Protecció Radiològica, Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
  • Hermida-López M; Servei de Física i Protecció Radiològica, Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Rep Pract Oncol Radiother ; 23(2): 121-125, 2018.
Article em En | MEDLINE | ID: mdl-29556140
ABSTRACT

AIM:

This work aims to achieve the highest possible monitor units (MU) reduction using the MU Objective tool included in the Eclipse treatment planning system, while preserving the plan quality.

BACKGROUND:

The treatment planning system Eclipse (Varian Medical Systems, Palo Alto, CA) includes a control mechanism for the number of monitor units of volumetric modulated arc therapy (VMAT) plans, named the MU Objective tool. MATERIAL AND

METHODS:

Forty prostate plans, 20 gynecological plans and 20 head and neck plans designed with VMAT were retrospectively studied. Each plan (base plan) was optimized without using the MU Objective tool, and it was re-optimized with different values of the Maximum MU (MaxMU) parameter of the MU Objective tool. MU differences were analyzed with a paired samples t-test and changes in plan quality were assessed with a set of parameters for OARs and PTVs.

RESULTS:

The average relative MU difference [Formula see text] considering all treatment sites, was the highest when MaxMU = 400 (-4.2%, p < 0.001). For prostate plans, the lowest [Formula see text] was obtained (-3.7%, p < 0.001). For head and neck plans [Formula see text] was -7.3% (p < 0.001) and for gynecological plans [Formula see text] was 7.0% (p = 0.002). Although similar MU reductions were observed for both sites, for some gynecological plans maximum differences were greater than 10%. All the assessed parameters for PTVs and OARs sparing showed average differences below 2%.

CONCLUSION:

For the three studied clinical sites, establishing MaxMU = 400 led to the optimum MU reduction, maintaining the original dose distribution and dosimetric parameters practically unaltered.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article